Clinical Trial Update: Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative bevacizumab with radiation therapy and XELOX chemotherapy for locally advanced nonmetastatic rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN